Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance

NCT ID: NCT01408498

Last Updated: 2012-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure, heart rate, and endocrine responses) and a decreased behavioral response (e.g., ignoring the threat, avoiding the threat, and postponing dealing with the threat). The threat in this study is a social threat involving public speaking, and is an outgrowth of previous research on the avoidance of health threats.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants in the study will receive either a single dose of 10g 1% testosterone topical gel or placebo the day prior to participating in the study. The day of the study, participants will provide saliva samples throughout the study to track testosterone and cortisol levels. Participants will be asked to complete the Trier Social Stressor Task, which includes having to give a 5 minute speech to a panel of judges. Participants will be given the opportunity to postpone giving their speech to an unspecified date. The study will focus on two types of responses to the threat of public speaking: behavioral and physiological. The behavior of interest will be participants desire to postpone dealing with the threat (it is hypothesized that those in the testosterone administration group will have an increased desire to postpone). The physiological responses include increased levels of cortisol and increased cardiovascular tone (it is hypothesized that the testosterone administration group will show an increased physiological response compared to the placebo group).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Testosterone's Effects on Threat Perception/Response

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Testosterone Social psychology Human behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Control

Control group who will not receive exogenous testosterone administration. Will act as a comparison group to the testosterone group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Testosterone administration group

Experimental group that will receive a single 10 g dose of 1% testosterone topical gel.

Group Type EXPERIMENTAL

Testosterone

Intervention Type DRUG

Topical administration of testosterone gel. Participants receive a one-time, single dose of 10 g of 1% testosterone gel.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Testosterone

Topical administration of testosterone gel. Participants receive a one-time, single dose of 10 g of 1% testosterone gel.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AngroGel

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* In good health
* Aged 18-35

Exclusion Criteria

* Female
* Known carcinoma of the breast or prostate
* Known sensitivity to alcohol or soy products
* Preexisting cardiac, renal, or hepatic diseases
* Obesity
* Chronic lung diseases
* Cancer
* Use of anticoagulants
* Use of insulin or a history of diabetes
* Use of corticosteroids
* High levels of physical contact with women or children
* Preexisting liver problems
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Scott Liening

Graduate Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scott H Liening, B.A.

Role: PRINCIPAL_INVESTIGATOR

University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seay Building

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHL-Diss-1

Identifier Type: -

Identifier Source: org_study_id